Evidence map›Paper›PMID 39066867›Full record

ArticleClinical rheumatology2024

Clinical characteristics of pediatric noninfectious uveitis and risk factors for severe disease: a single-center study.

Lutfiye Koru, Fehim Esen, Ozlem Turkyilmaz, Elif Kucuk, Feray Kaya, Zelal Aydin, Fatih Haslak, Kubra Ozturk

Abstract read
In one paragraph

Article in Clinical rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. [Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lutfiye KoruDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-0358-8204
Fehim EsenDepartment of Ophthalmology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-9948-5575
Ozlem TurkyilmazDepartment of Ophthalmology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0293-0415
Elif KucukDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0009-0004-1063-7459
Feray KayaDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0009-0000-9947-8298
Zelal AydinDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0009-0009-4741-2460
Fatih HaslakDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-6963-9668
Kubra OzturkDepartment of Pediatric Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey. ozturk1209@gmail.com.ORCID http://orcid.org/0000-0003-0466-0228

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to present the demographic, clinical, laboratory, and treatment data of children with non-infectious uveitis and to evaluate the risk factors for the development of complications and the need for biological treatment.

methodPatients diagnosed with non-infectious uveitis in childhood and followed up for at least 1 year were included in the study. Demographic data, including age, gender, age at diagnosis, uveitis in first-degree relatives, and rheumatologic diseases, were obtained retrospectively from medical records. The presence of complications or the need for biologic therapy was considered a composite outcome suggesting severe disease.

resultsThe study included 123 patients (female: n = 59, 48%). The mean age at diagnosis was 14.89 ± 4.86 years. Uveitis was symptomatic in 104 patients (84.6%). Approximately one-quarter of the patients had at least one rheumatic disease (n = 35, 28.5%), the most common being juvenile idiopathic arthritis. Thirty-three patients (26.8%) had anti-nuclear antibody positivity. Biologic agents were needed in 60 patients (48.8%). Complications developed in 14 patients (11.4%). Early age at disease onset (aOR, 0.875; 95% C.I. 0.795-0.965, p = 0.007) and female gender (aOR, 2.99; 95% C.I. 1.439-6.248, p = 0.003) were significantly associated with the need for biologic treatment, while Behçet's disease (BD) was strongly associated with uveitis-related complications (aOR, 14.133; 95% C.I. 2.765-72.231, p = 0.001).

conclusionWe suggest that among pediatric patients with non-infectious uveitis, females, those with an early age of disease onset, and those with BD need to be closely monitored due to a significantly increased risk of severe disease. Key Points • Limited data exist on the clinical course of non-infectious uveitis in children and the associated risk factors for severe disease. • Our study reveals that nearly a quarter of pediatric patients with non-infectious uveitis also have a rheumatic disease. • Among pediatric patients diagnosed with non-infectious uveitis, we observed an increased risk of severe disease in those with an earlier onset age, in female patients, and in those diagnosed with Behçet's disease.

Indexed as

UveitisAdolescentAge of OnsetChildChild, PreschoolFemaleHumansMaleRetrospective StudiesRisk FactorsSeverity of Illness IndexSex FactorsDisease severityImmunosuppressive therapyPediatricsUveitis

Identifiers

PMID39066867
PMCPMC11330385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.